+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Essential Human Virology. Edition No. 2

  • Book

  • August 2022
  • Elsevier Science and Technology
  • ID: 5483880

*Textbook and Academic Authors Association (TAA) Textbook Excellence Award Winner, 2024* Essential Human Virology, Second Edition focuses on the structure and classification of viruses, virus transmission and virus replication strategies based upon type of viral nucleic acid. Several chapters focus on notable and recognizable viruses and the diseases caused by them, including influenza, HIV, hepatitis viruses, poliovirus, herpesviruses and emerging and dangerous viruses. Additionally, how viruses cause disease (pathogenesis) is highlighted, along with discussions on immune response to viruses, vaccines, anti-viral drugs, gene therapy, the beneficial uses of viruses, research laboratory assays and viral diagnosis assays.

Fully revised and updated with new chapters on coronaviruses, nonliving infectious agents, and notable non-human viruses, the book provides students with a solid foundation in virology.

Table of Contents

1. Introduction
2. Viral Structure and Classification
3. Features of Host Cells: Molecular and Cellular Biology Review
4. Virus Replication
5. Virus Transmission, Entry, and Spread
6. The Immune Response to Viruses
7. Virology Research and Diagnosis of Viral Infections
8. Vaccines, Anti-Virals, and the Beneficial Uses of Viruses
9. Viruses and Cancer
10. Influenza
11. Human Immunodeficiency Virus (HIV)
12. Hepatitis Viruses
13. Herpesviruses
14. Coronaviruses
15. Poliovirus
16. Poxviruses
17. Emerging and dangerous viruses
18. Notable Non-Human Viruses and Nonliving Infectious Agents
Appendices
1. Abbreviations
2. Glossary

Authors

Jennifer Louten Professor of Biology; Director, Scholars in STEM Program; Director, Advanced Majors Program, Kennesaw State University, Kennesaw, GA, USA. Jennifer Louten is currently a Professor of Biology at Kennesaw State University in Georgia, USA. She has served as a Teaching Fellow and has developed courses in virology, biotechnology, immunology, and cell culture techniques. She is the recipient of an Outstanding Teaching Award, Outstanding Early Career Faculty Award, and the Student Government Association's Faculty of the Year Award. She received her Ph.D. from Brown University Medical School, where she investigated the cellular targets of infection and the induction of type 1 interferons following infection with lymphocytic choriomeningitis virus. Before joining academia, Dr. Louten performed research in drug discovery at Schering-Plough Biopharma (currently Merck Research Laboratories). She received her Bachelor of Science in biotechnology from the Rochester Institute of Technology.